The US government "has made Deutsche Bank admit to its actions designed to avoid taxes and pay $95 million to the United States to account for this conduct," the prosecutor said in a statement Wednesday. The case dates back to 2000 with Deutsche Bank's acquisition of a US holding company, Charter, which had stock in Bristol-Myers Squibb, the pharmaceutical company. To avoid paying high taxes on the gain from the sale of the stock, Deutsche Bank is alleged to have arranged to sell it to a shell company, and then to buy it back.
Copyright Agence France-Presse, 2017